<DOC>
	<DOC>NCT00872560</DOC>
	<brief_summary>This trial is conducted in Europe. This trial aims to ensure that there is no substantial clinically relevant difference between the two Novo Nordisk needles NovoFine速 6 x 0.30 mm and NovoFine速 8 x 0.30 mm on reflux of insulin back to the surface of cutis.</brief_summary>
	<brief_title>Comparison of 2 NovoFine速 Needles on the Reflux of Insulin</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 1</mesh_term>
	<criteria>Children/adolescents with type 1 diabetes mellitus Usage of NovoPen速 1.5 for at least 3 months Duration of insulin treatment more than 1 year Normal weight according to Tanner scales The means of the last 2 HbA1c measurements taken within the last 6 months must be less than 10.5% Pregnancy or desire to become pregnant Clinical relevant peripheral neuropathy as judged by the investigators Pronounced lipodystrophy in accordance with investigator's evaluation Use of drugs that can influence the trial Coagulation disorders (use of anticoagulants) Serious, chronic diseases, making it highly unlikely that the subject can complete the trial</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>